トップページ > グループ紹介 > BNCT医療開発分野(築地) > 業績

業績

2023年度

雑誌論文

  1. Eguchi K, Omura G, Shimoi T, Kageyama D, Igaki H, Abe Y, Watanabe T, Aihara Y, Sakai A, Matsumoto Y, Sakai T, Yonemori K, Mori T, Yoshida A, Yoshimoto S. BCOR-CCNB3 sarcoma arising in the pharynx. Auris Nasus Larynx. 2023 Aug;50(4):618-22. PubMed PMID: 35545465. Epub 20220508. eng.
  2. Matsumura A, Asano T, Hirose K, Igaki H, Kawabata S, Kumada H. Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan. Cancer Biother Radiopharm. 2023 Apr;38(3):201-7. PubMed PMID: 36374236. Pubmed Central PMCID: PMC10122211. Epub 20221114. eng.
  3. Nakaichi T, Okamoto H, Kon M, Takaso K, Aikawa A, Nakamura S, Ijima K, Chiba T, Nakayama H, Takemori M, Mikasa S, Fujii K, Urago Y, Goka T, Shimizu Y, Igaki H. Commissioning and performance evaluation of commercially available mobile imager for image guided total body irradiation. J Appl Clin Med Phys. 2023 Apr;24(4):e13865. PubMed PMID: 36573258. Pubmed Central PMCID: PMC10113699. Epub 20221226. eng.
  4. Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AI, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Kunitake N, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer. J Gynecol Oncol. 2023 May;34(3):e24. PubMed PMID: 36603849. Pubmed Central PMCID: PMC10157336. Epub 20221221. eng.
  5. Murakami N, Masui K, Yoshida K, Noda SE, Watanabe M, Takenaka T, Ii N, Atsumi K, Umezawa R, Inaba K, Iijima K, Kubo A, Igaki H, Shikama N, Ikushima H. Hands-on seminar for image-guided adaptive brachytherapy and intracavitary/interstitial brachytherapy for uterine cervical cancer. Jpn J Clin Oncol. 2023 Jun 1;53(6):508-13. PubMed PMID: 36810684. eng.
  6. Nakayama H, Okamoto H, Nakamura S, Iijima K, Chiba T, Takemori M, Nakaichi T, Mikasa S, Fujii K, Sakasai T, Kuwahara J, Miura Y, Fujiyama D, Tsunoda Y, Hanzawa T, Igaki H, Chang W. Film measurement and analytical approach for assessing treatment accuracy and latency in a magnetic resonance-guided radiotherapy system. J Appl Clin Med Phys. 2023 May;24(5):e13915. PubMed PMID: 36934441. Pubmed Central PMCID: PMC10161048. Epub 20230319. eng.
  7. Okamoto H, Murakami N, Isohashi F, Kasamatsu T, Hasumi Y, Kobayashi H, Ishikawa M, Nakamura M, Nishio T, Igaki H, Ishikura S, Yaegashi N, Mizowaki T, Nishimura Y, Toita T. Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan clinical Oncology Group study (JCOG1402). Radiother Oncol. 2023 Jun;183:109630. PubMed PMID: 36934892. Epub 20230318. eng.
  8. Yoshida K, Kotsuma T, Takaoka Y, Tamenaga S, Yamazaki H, Nose T, Murakami N, Inaba K, Akiyama H, Masui K, Takenaka T, Kubota H, Tselis N, Masuda N, Yasojima H, Takeda M, Mano M, Nakamura S, Utsunomiya K, Tanigawa N, Tanaka E. HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution. J Contemp Brachytherapy. 2023 Feb;15(1):1-8. PubMed PMID: 36970436. Pubmed Central PMCID: PMC10034731. Epub 20230228.
  9. Doi Y, Nagata Y, Matsumoto Y, Numata K, Sasaki R, Yamada T, Igaki H, Imagumbai T, Katoh N, Yoshitake T, Shimizuguchi T, Fujioka D, Inoue M, Koide Y, Kimura T, Ito Y. Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma. Hepatol Res. 2023 Aug;53(8):749-60. PubMed PMID: 37036153. Epub 20230425. eng.
  10. Nakamura M, Zhou D, Minemura T, Kito S, Okamoto H, Tohyama N, Kurooka M, Kumazaki Y, Ishikawa M, Clark CH, Miles E, Lehmann J, Andratschke N, Kry S, Ishikura S, Mizowaki T, Nishio T. A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study. J Appl Clin Med Phys. 2023 Jun;24(6):e14040. PubMed PMID: 37191875. Pubmed Central PMCID: PMC10243313. Epub 20230516.
  11. Yoshioka Y, Sasamura K, Ito M, Kaneko M, Takahashi T, Anno W, Shimoyachi N, Suzuki J, Okuda T, Kashihara T, Inaba K, Igaki H, Itami J. Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer. Phys Imaging Radiat Oncol. 2023 Apr;26:100445. PubMed PMID: 37197153. Pubmed Central PMCID: PMC10183665. Epub 20230504. eng.
  12. Imaizumi J, Shida D, Boku N, Igaki H, Itami J, Miyakita Y, Narita Y, Takashima A, Kanemitsu Y. Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer. Int J Clin Oncol. 2023 Aug;28(8):1043-53. PubMed PMID: 37208499. Pubmed Central PMCID: PMC10390364. Epub 20230519. eng.
  13. Nakamura S, Imamichi S, Shimada K, Takemori M, Kanai Y, Iijima K, Chiba T, Nakayama H, Nakaichi T, Mikasa S, Urago Y, Kashihara T, Takahashi K, Nishio T, Okamoto H, Itami J, Ishiai M, Suzuki M, Igaki H, Masutani M. Relative biological effectiveness for epithermal neutron beam contaminated with fast neutrons in the linear accelerator-based boron neutron capture therapy system coupled to a solid-state lithium target. J Radiat Res. 2023 Jul 18;64(4):661-7. PubMed PMID: 37295954. Pubmed Central PMCID: PMC10354855. eng.
  14. Murakami N, Nakatani F, Takahashi K, Nakamura S, Igaki H, Shikama N. Salvage high-dose rate brachytherapy for myxofibrosarcoma of the brachium: a technical report. J Radiat Res. 2023 Jul 18;64(4):746-9. PubMed PMID: 37301983. Pubmed Central PMCID: PMC10354856. eng.
  15. Kishigami Y, Nakamura M, Nakao M, Okamoto H, Takahashi A, Igaki H. Three-dimensional assessment of interfractional cervical and uterine motions using daily magnetic resonance images to determine margins and timing of replanning. J Appl Clin Med Phys. 2023 Oct;24(10):e14073. PubMed PMID: 37317937. Pubmed Central PMCID: PMC10562032. Epub 20230615. eng.
  16. Adachi M, Matsumoto Y, Furuse H, Uchimura K, Imabayashi T, Yotsukura M, Yoshida Y, Nakagawa K, Igaki H, Watanabe SI, Tsuchida T. Utility of the endobronchial Watanabe spigot for intractable cancer-related pneumothorax: a retrospective observational study. Jpn J Clin Oncol. 2023 Aug 30;53(9):829-36. PubMed PMID: 37340759. Pubmed Central PMCID: PMC10473273. eng.
  17. Eguchi K, Omura G, Murakami N, Honma Y, Yokoyama K, Watanabe T, Aihara Y, Sakai A, Matsumoto Y, Sakai T, Kobayashi K, Igaki H, Yoshimoto S. Comparison of Survival Outcomes Between Larynx-Preserving Open Partial Pharyngectomy and Radiotherapy or Chemoradiotherapy in Patients with Hypopharyngeal Squamous Cell Carcinoma: A Single-Center Retrospective Analysis with Inverse Probability of Treatment Weighting Adjustments. Ann Surg Oncol. 2023 Oct;30(11):6867-74. PubMed PMID: 37452169. Epub 20230714. eng.
  18. Kawauchi D, Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Omura T, Yoshida A, Kubo Y, Igaki H, Ichimura K, Narita Y. Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients. Jpn J Clin Oncol. 2023 Nov 5;53(11):1027-33. PubMed PMID: 37534529. eng.
  19. Murakami N, Kojima K, Okuma K, Kashihara T, Nakamura S, Shimizu W, Suda R, Igaki H, Shikama N. Non-operative management involving chemoradiation therapy combined with high-dose-rate brachytherapy for T3 rectal cancer using a vaginal shielded cylindrical applicator: a technical report. Jpn J Clin Oncol. 2023 Nov 5;53(11):1082-6. PubMed PMID: 37554048. eng.
  20. Egashira M, Arimura H, Kobayashi K, Moriyama K, Kodama T, Tokuda T, Ninomiya K, Okamoto H, Igaki H. Magnetic resonance-based imaging biopsy with signatures including topological Betti number features for prediction of primary brain metastatic sites. Phys Eng Sci Med. 2023 Dec;46(4):1411-26. PubMed PMID: 37603131. Epub 20230821. eng.
  21. Tohyama N, Okamoto H, Shimomura K, Kurooka M, Kawamorita R, Ota S, Kojima T, Hayashi N, Okumura M, Nakamura M, Nakamura M, Myojoyama A, Onishi H. A national survey on the medical physics workload of external beam radiotherapy in Japandagger. J Radiat Res. 2023 Nov 21;64(6):911-25. PubMed PMID: 37816672. Pubmed Central PMCID: PMC10665301.
  22. Nagao A, Okamoto H, Nakayama H, Chiba T, Fujiyama D, Kuwahara J, Sakasai T, Kashihara T, Kaneda T, Inaba K, Okuma K, Murakami N, Igaki H. Assessment of intrafractional motion of the cervix-uterus by MR-guided radiotherapy system†. J Radiat Res. 2023 Nov 21;64(6):967-72. PubMed PMID: 37816679. Pubmed Central PMCID: PMC10665310. eng.
  23. Kashihara T, Mori T, Nakaichi T, Nakamura S, Ito K, Kurihara H, Kusumoto M, Itami J, Yoshimoto S, Igaki H. Correlation between L-amino acid transporter 1 expression and 4-borono-2-(18) F-fluoro-phenylalanine accumulation in humans. Cancer Med. 2023 Nov;12(21):20564-72. PubMed PMID: 37881128. Pubmed Central PMCID: PMC10660410. Epub 20231025. eng.
  24. Igaki H, Nakamura S, Yamazaki N, Kaneda T, Takemori M, Kashihara T, Murakami N, Namikawa K, Nakaichi T, Okamoto H, Iijima K, Chiba T, Nakayama H, Nagao A, Sakuramachi M, Takahashi K, Inaba K, Okuma K, Nakayama Y, Shimada K, Nakagama H, Itami J. Acral cutaneous malignant melanoma treated with linear accelerator-based boron neutron capture therapy system: a case report of first patient. Front Oncol. 2023;13:1272507. PubMed PMID: 37901311. Pubmed Central PMCID: PMC10613025. Epub 20231013. eng.
  25. Kishigami Y, Nakamura M, Okamoto H, Takahashi A, Iramina H, Sasaki M, Kawata K, Igaki H. Organ-contour-driven auto-matching algorithm in image-guided radiotherapy. J Appl Clin Med Phys. 2024 Jan;25(1):e14220. PubMed PMID: 37994694. Pubmed Central PMCID: PMC10795436. Epub 20231123. eng.
  26. Nakahara M, Murakami N, Chiba T, Nagao A, Okuma K, Kashihara T, Kaneda T, Takahashi K, Inaba K, Nakayama Y, Kato T, Igaki H. Gynecological technical notes for appropriate spacer injections. Brachytherapy. 2024 Jan-Feb;23(1):45-51. PubMed PMID: 38040606. Epub 20231130. eng.
  27. Wada S, Ogata D, Kashihara T, Okuma K, Eto H, Nakano E, Takahashi A, Namikawa K, Igaki H, Yamazaki N. A single-center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan. Cancer Med. 2023 Dec;12(24):21933-43. PubMed PMID: 38083908. Pubmed Central PMCID: PMC10757137. Epub 20231211. eng.
  28. Kobayashi K, Gu L, Hataya R, Mizuno T, Miyake M, Watanabe H, Takahashi M, Takamizawa Y, Yoshida Y, Nakamura S, Kouno N, Bolatkan A, Kurose Y, Harada T, Hamamoto R. Sketch-based semantic retrieval of medical images. Med Image Anal. 2024 Feb;92:103060. PubMed PMID: 38104401. Epub 20231208.
  29. Nakao M, Ozawa S, Miura H, Yamada K, Hayata M, Hayashi K, Kawahara D, Nakashima T, Ochi Y, Okumura T, Kunimoto H, Kawakubo A, Kusaba H, Nozaki H, Habara K, Tohyama N, Nishio T, Nakamura M, Minemura T, Okamoto H, Ishikawa M, Kurooka M, Shimizu H, Hotta K, Saito M, Nakano M, Tsuneda M, Nagata Y. CT number calibration audit in photon radiation therapy. Med Phys. 2024 Mar;51(3):1571-82. PubMed PMID: 38112216. Epub 20231219.
  30. Kito S, Suda Y, Tanabe S, Takizawa T, Nagahata T, Tohyama N, Okamoto H, Kodama T, Fujita Y, Miyashita H, Shinoda K, Kurooka M, Shimizu H, Ohno T, Sakamoto M. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan. J Radiat Res. 2024 Mar 22;65(2):159-67. PubMed PMID: 38151953. Pubmed Central PMCID: PMC10959444.
  31. Sakuramachi M, Murakami N, Nagao A, Kojima K, Miyata Y, Kashihara T, Kaneda T, Takahashi K, Inaba K, Okuma K, Nakayama Y, Okamoto H, Ishikawa M, Igaki H. Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report. J Contemp Brachytherapy. 2023 Dec;15(6):465-9. PubMed PMID: 38230404. Pubmed Central PMCID: PMC10789158. Epub 20231229. eng.
  32. Murakami Y, Kawahara D, Soyano T, Kozuka T, Takahashi Y, Miyake K, Kashihara K, Kashihara T, Kamima T, Oguchi M, Murakami Y, Yoshioka Y, Nagata Y. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study. Br J Radiol. 2024 Jan 23;97(1153):142-9. PubMed PMID: 38263831.
  33. Cho H, Abe S, Nonaka S, Suzuki H, Yoshinaga S, Okuma K, Yamamoto S, Daiko H, Kato K, Sekine S, Boku N, Saito Y. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy. Dis Esophagus. 2024 Jan 23. PubMed PMID: 38266034. Epub 20240123.
  34. Okamoto H, Wakita A, Tani K, Kito S, Kurooka M, Kodama T, Tohyama N, Fujita Y, Nakamura S, Iijima K, Chiba T, Nakayama H, Murata M, Goka T, Igaki H. Plan complexity metrics for head and neck VMAT competition plans. Med Dosim. 2024 Feb 16. PubMed PMID: 38368182. Epub 20240216. eng.
  35. Nishioka S, Okamoto H, Chiba T, Kito S, Ishihara Y, Isono M, Ono T, Mizoguchi A, Mizuno N, Tohyama N, Kurooka M, Ota S, Shimizu D. Technical note: A universal worksheet for failure mode and effects analysis-A project of the Japanese College of Medical Physics. Med Phys. 2024 Mar 20. PubMed PMID: 38507277. Epub 20240320.

2022年度

雑誌論文

  1. Soyano T, Kozuka T, Kashihara K, Murakami Y, Yonese J, Sasamura K, Shimoyachi N, Kashihara T, Yoshioka Y, Oguchi M. Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era? Jpn J Clin Oncol. 2023 Mar 21. PubMed PMID: 36946312. doi: 10.1093/jjco/hyad019.
  2. Okamoto H, Murakami N, Isohashi F, Kasamatsu T, Hasumi Y, Kobayashi H, Ishikawa M, Nakamura M, Nishio T, Igaki H, Ishikura S, Yaegashi N, Mizowaki T, Nishimura Y, Toita T. Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan clinical Oncology Group study (JCOG1402). Radiother Oncol. 2023 Mar 18;183:109630. PubMed PMID: 36934892. doi: 10.1016/j.radonc.2023.109630.
  3. Nakayama H, Okamoto H, Nakamura S, Iijima K, Chiba T, Takemori M, Nakaichi T, Mikasa S, Fujii K, Sakasai T, Kuwahara J, Miura Y, Fujiyama D, Tsunoda Y, Hanzawa T, Igaki H, Chang W. Film measurement and analytical approach for assessing treatment accuracy and latency in a magnetic resonance-guided radiotherapy system. J Appl Clin Med Phys. 2023 Mar 19:e13915. PubMed PMID: 36934441. doi: 10.1002/acm2.13915.
  4. Murakami N, Masui K, Yoshida K, Noda SE, Watanabe M, Takenaka T, Ii N, Atsumi K, Umezawa R, Inaba K, Iijima K, Kubo A, Igaki H, Shikama N, Ikushima H. Hands-on seminar for image-guided adaptive brachytherapy and intracavitary/interstitial brachytherapy for uterine cervical cancer. Jpn J Clin Oncol. 2023 Feb 21. PubMed PMID: 36810684. doi: 10.1093/jjco/hyad012.
  5. Kashihara T, Nakayama Y, Okuma K, Takahashi A, Kaneda T, Katagiri M, Nakayama H, Kubo Y, Ito K, Nakamura S, Takahashi K, Inaba K, Murakami N, Saito T, Okamoto H, Itami J, Kusumoto M, Ohe Y, Igaki H. Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer. Radiother Oncol. 2023 Mar;180:109454. PubMed PMID: 36640944. doi: 10.1016/j.radonc.2022.109454.
  6. Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito AI, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Kunitake N, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Phase I/II prospective clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer. J Gynecol Oncol. 2022 Dec 21. PubMed PMID: 36603849. doi: 10.3802/jgo.2023.34.e24.
  7. Nakaichi T, Okamoto H, Kon M, Takaso K, Aikawa A, Nakamura S, Ijima K, Chiba T, Nakayama H, Takemori M, Mikasa S, Fujii K, Urago Y, Goka T, Shimizu Y, Igaki H. Commissioning and performance evaluation of commercially available mobile imager for image guided total body irradiation. J Appl Clin Med Phys. 2022 Dec 26:e13865. PubMed PMID: 36573258. doi: 10.1002/acm2.13865.
  8. Mizuno N, Okamoto H, Minemura T, Kawamura S, Tohyama N, Kurooka M, Kawamorita R, Nakamura M, Ito Y, Shioyama Y, Aoyama H, Igaki H. Establishing quality indicators to comprehensively assess quality assurance and patient safety in radiotherapy and their relationship with an institution's background. Radiother Oncol. 2023 Feb;179:109452. PubMed PMID: 36572282. doi: 10.1016/j.radonc.2022.109452.
  9. Nakaichi T, Nakamura S, Ito K, Takahashi K, Takemori M, Kashihara T, Kunito K, Murakami N, Iijima K, Chiba T, Nakayama H, Mikasa S, Nishio T, Okamoto H, Itami J, Kurihara H, Igaki H. Analyzing spatial distribution between (18)F-fluorodeoxyglucose and (18)F-boronophenylalanine positron emission tomography to investigate selection indicators for boron neutron capture therapy. EJNMMI Phys. 2022 Dec 19;9(1):89. PubMed PMID: 36536190. Pubmed Central PMCID: 9763526. doi: 10.1186/s40658-022-00514-7.
  10. Yazaki S, Salgado R, Shimoi T, Yoshida M, Shiino S, Kaneda T, Kojima Y, Sumiyoshi-Okuma H, Nishikawa T, Sudo K, Noguchi E, Murata T, Takayama S, Suto A, Ohe Y, Yonemori K. Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. Br J Cancer. 2023 Feb;128(4):568-75. PubMed PMID: 36522476. Pubmed Central PMCID: 9938235 research support from Merck, Puma Biotechnology and Roche, and personal fees from Roche, BMS and Exact Sciences for advisory boards, outside the submitted work. MY reports no competing non-financial interests but personal fees from Chugai, outside the submitted work; TN reports no competing non-financial interests, but personal fees from Takeda Pharmaceutical Company, Eisai, AstraZeneca, Taiho, MSD, outside the submitted work; YO reports no competing non-financial interests, but grants and personal fees from AstraZeneca, Amgen, BMS, Chugai, Eli Lilly, Janssen, Kyorin, Nippon Kayaku, Novartis, Ono Pharmaceutical Company, MSD, Pfizer, Taiho, and Takeda Pharmaceutical Company, personal fees from Boehringer Ingelheim and Celtrion, and grants from Kissei, outside the submitted work; KY reports no competing non-financial interests, but personal fees from Pfizer, AstraZeneca, Eisai, Takeda Pharmaceutical Company, Chugai, Ono Pharmaceutical Company, Novartis, Daiichi Sankyo, outside the submitted work. All remaining authors declare no competing financial or non-financial interest. doi: 10.1038/s41416-022-02072-2.
  11. Murakami N, Takano A, Niizeki I, Sakuramachi M, Kashihara T, Okamoto H, Ito M, Ueno T, Igaki H. Nursing management of patients receiving interstitial brachytherapy for head and neck malignancies. Brachytherapy. 2023 Mar-Apr;22(2):214-20. PubMed PMID: 36428156. doi: 10.1016/j.brachy.2022.10.010.
  12. Takemori M, Nakamura S, Sofue T, Ito M, Goka T, Miura Y, Iijima K, Chiba T, Nakayama H, Nakaichi T, Mikasa S, Takano Y, Kon M, Shuto Y, Urago Y, Nishitani M, Kashihara T, Takahashi K, Murakami N, Nishio T, Okamoto H, Chang W, Igaki H. Failure modes and effects analysis study for accelerator-based Boron Neutron Capture Therapy. Med Phys. 2023 Jan;50(1):424-39. PubMed PMID: 36412161. doi: 10.1002/mp.16104.
  13. Kashihara T, Ogata D, Okuma K, Nakamura S, Nakayama H, Mori T, Takahashi A, Namikawa K, Takahashi A, Takahashi K, Kaneda T, Inaba K, Murakami N, Okamoto H, Nakayama Y, Yamazaki N, Igaki H. Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas. Skin Res Technol. 2023 Jan;29(1):e13243. PubMed PMID: 36404577. doi: 10.1111/srt.13243.
  14. Matsumura A, Asano T, Hirose K, Igaki H, Kawabata S, Kumada H. Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan. Cancer Biother Radiopharm. 2023 Apr;38(3):201-7. PubMed PMID: 36374236. doi: 10.1089/cbr.2022.0056.
  15. Murakami N, Okuma K, Takahashi A, Kato T, Igaki H. Is it time to modify the Japanese Uterine Cervical Cancer Guidelines to recommend a higher dose for radio-resistant tumors? Jpn J Clin Oncol. 2023 Jan 28;53(2):179-81. PubMed PMID: 36373890. doi: 10.1093/jjco/hyac171.
  16. Asami Y, Hiranuma K, Takayanagi D, Matsuda M, Shimada Y, Kato MK, Kuno I, Murakami N, Komatsu M, Hamamoto R, Kohno T, Sekizawa A, Matsumoto K, Kato T, Yoshida H, Shiraishi K. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer. Sci Rep. 2022 Nov 8;12(1):19004. PubMed PMID: 36347927. Pubmed Central PMCID: 9643353. doi: 10.1038/s41598-022-23252-3.
  17. Kon M, Okamoto H, Nakamura S, Iijima K, Chiba T, Takemori M, Nakayama H, Nakaichi T, Mikasa S, Fujii K, Urago Y, Ishikawa M, Sofue T, Katsuta S, Inaba K, Igaki H, Aso T. Planning study: prone versus supine position for stereotactic body radiotherapy in prostate by CyberKnife. J Radiat Res. 2023 Jan 20;64(1):186-94. PubMed PMID: 36316958. Pubmed Central PMCID: 9855311. doi: 10.1093/jrr/rrac065.
  18. Hosoya T, Takahashi M, Davey C, Sese J, Honda-Kitahara M, Miyakita Y, Ohno M, Yanagisawa S, Omura T, Kawauchi D, Ozeki Y, Kikuchi M, Nakano T, Yoshida A, Igaki H, Matsushita Y, Ichimura K, Narita Y. Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy. Biomolecules. 2022 Sep 26;12(10):1379. PubMed PMID: 36291588. Pubmed Central PMCID: 9599060. doi: 10.3390/biom12101379.
  19. Okonogi N, Murakami N, Ando K, Murata M, Murata K, Aoshika T, Kato S, Saito AI, Kim JY, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Ohno T, Itami J. An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma. J Contemp Brachytherapy. 2022 Aug;14(4):311-20. PubMed PMID: 36199951. Pubmed Central PMCID: 9528827. doi: 10.5114/jcb.2022.119451.
  20. Nakano T, Aoyama H, Onodera S, Igaki H, Matsumoto Y, Kanemoto A, Shimamoto S, Matsuo M, Tanaka H, Oya N, Matsuyama T, Ohta A, Maruyama K, Tanaka T, Kitamura N, Akazawa K, Maebayashi K, Japanese Radiation Oncology Study Group I. Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control. Clin Transl Radiat Oncol. 2022 Nov;37:116-29. PubMed PMID: 36199814. Pubmed Central PMCID: 9529504. doi: 10.1016/j.ctro.2022.09.005.
  21. Ishiguro A, Ogata D, Okuma K, Kashihara T, Murakami N, Hiki K, Yamakawa K, Jinnai S, Takahashi A, Namikawa K, Igaki H, Yamazaki N. Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series. J Dermatol. 2023 Jan;50(1):94-7. PubMed PMID: 36196042. doi: 10.1111/1346-8138.16599.
  22. Miyata Y, Murakami N, Honma Y, Mori T, Yoshimoto S, Kashihara T, Takemori M, Nakayama Y, Itami J, Ogo E, Igaki H. Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma. J Radiat Res. 2022 Dec 6;63(6):879-83. PubMed PMID: 36149017. Pubmed Central PMCID: 9726697. doi: 10.1093/jrr/rrac054.
  23. Miyata Y, Murakami N, Honma Y, Mori T, Yoshimoto S, Kashihara T, Takemori M, Nakayama Y, Itami J, Ogo E, Igaki H. Technical report: a high-dose-rate interstitial brachytherapy boost for residual sinonasal undifferentiated carcinoma. J Radiat Res. 2022 Dec 6;63(6):879-83. PubMed PMID: 36149017. Pubmed Central PMCID: 9726697. doi: 10.1093/jrr/rrac054.
  24. Shimizu Y, Murakami N, Mori T, Takahashi K, Kubo Y, Yoshimoto S, Honma Y, Nakamura S, Okamoto H, Iijima K, Takahashi A, Kaneda T, Kashihara T, Inaba K, Okuma K, Nakayama Y, Igaki H, Itami J. Clinical impact of p16 positivity in nasopharyngeal carcinoma. Laryngoscope Investig Otolaryngol. 2022 Aug;7(4):994-1001. PubMed PMID: 36000039. Pubmed Central PMCID: 9392382. doi: 10.1002/lio2.832.
  25. Kubo S, Shinkawa H, Asaoka Y, Ioka T, Igaki H, Izumi N, Itoi T, Unno M, Ohtsuka M, Okusaka T, Kadoya M, Kudo M, Kumada T, Kokudo N, Sakamoto M, Sakamoto Y, Sakurai H, Takayama T, Nakashima O, Nagata Y, Hatano E, Harada K, Murakami T, Yamamoto M. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma. Liver Cancer. 2022 Jul;11(4):290-314. PubMed PMID: 35978598. Pubmed Central PMCID: 9294959. doi: 10.1159/000522403.
  26. Takamori H, Urabe F, Matsuzaki J, Kimura S, Sasaki H, Kimura T, Inaba K, Nakamura E, Matsui Y, Fujimoto H, Ochiya T. Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy. Prostate. 2022 Dec;82(16):1537-46. PubMed PMID: 35971801. doi: 10.1002/pros.24427.
  27. Kawauchi D, Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Omura T, Yoshida A, Kubo Y, Igaki H, Ichimura K, Narita Y. Early Diagnosis and Surgical Intervention Within 3 Weeks From Symptom Onset Are Associated With Prolonged Survival of Patients With Glioblastoma. Neurosurgery. 2022 Nov 1;91(5):741-8. PubMed PMID: 35951724. Pubmed Central PMCID: 9531976. doi: 10.1227/neu.0000000000002096.
  28. Okamoto H, Igaki H, Chiba T, Shibuya K, Sakasai T, Jingu K, Inaba K, Kuroda K, Aoki S, Tatsumi D, Nakamura M, Kadoya N, Furuyama Y, Kumazaki Y, Tohyama N, Tsuneda M, Nishioka S, Itami J, Onishi H, Shigematsu N, Uno T. Practical guidelines of online MR-guided adaptive radiotherapy. J Radiat Res. 2022 Sep 21;63(5):730-40. PubMed PMID: 35946325. Pubmed Central PMCID: 9494538. doi: 10.1093/jrr/rrac048.
  29. Inada M, Nishimura Y, Ishikura S, Ishikawa K, Murakami N, Kodaira T, Ito Y, Tsuchiya K, Murakami Y, Saito J, Akimoto T, Nakata K, Yoshimura M, Teshima T, Toshiyasu T, Ota Y, Minemura T, Shimizu H, Hiraoka M. Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1). Radiat Oncol. 2022 Jul 28;17(1):133. PubMed PMID: 35902868. Pubmed Central PMCID: 9331577. doi: 10.1186/s13014-022-02105-3.
  30. Okumura M, Ogata D, Namikawa K, Tsutsui K, Takahashi A, Okuma K, Kashihara T, Igaki H, Akiyama M, Yamazaki N. Postoperative radiation therapy improves prognoses in extramammary Paget's disease presenting with multiple lymph node metastases. J Dermatol. 2022 Oct;49(10):1005-11. PubMed PMID: 35769003. doi: 10.1111/1346-8138.16491.
  31. Miyata Y, Murakami N, Okuma K, Shimizu Y, Takahashi A, Kashihara T, Kaneda T, Takahashi K, Inaba K, Sakuramachi M, Kojima K, Aoshika T, Morishima K, Nakayama Y, Itami J, Kato T, Ogo E, Igaki H. Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies. Brachytherapy. 2022 Sep-Oct;21(5):647-57. PubMed PMID: 35750619. doi: 10.1016/j.brachy.2022.04.009.
  32. Murakami N, Okuma K, Kato T, Igaki H. Now is it time to implement spacers in cervical cancer brachytherapy? J Radiat Res. 2022 Jul 19;63(4):696-8. PubMed PMID: 35726343. Pubmed Central PMCID: 9303596. doi: 10.1093/jrr/rrac031.
  33. Nishioka S, Okamoto H, Chiba T, Sakasai T, Okuma K, Kuwahara J, Fujiyama D, Nakamura S, Iijima K, Nakayama H, Takemori M, Tsunoda Y, Kaga K, Igaki H. Identifying risk characteristics using failure mode and effect analysis for risk management in online magnetic resonance-guided adaptive radiation therapy. Phys Imaging Radiat Oncol. 2022 Jul;23:1-7. PubMed PMID: 35712526. Pubmed Central PMCID: 9194450. doi: 10.1016/j.phro.2022.06.002.
  34. Kobayashi R, Murakami N, Chiba T, Okuma K, Inaba K, Takahashi K, Kaneda T, Kashihara T, Takahashi A, Shimizu Y, Nakayama Y, Kato T, Ito Y, Igaki H. Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer. Adv Radiat Oncol. 2022 May-Jun;7(3):100918. PubMed PMID: 35647394. Pubmed Central PMCID: 9133393. doi: 10.1016/j.adro.2022.100918.
  35. Omura T, Takahashi M, Ohno M, Miyakita Y, Yanagisawa S, Tamura Y, Kikuchi M, Kawauchi D, Nakano T, Hosoya T, Igaki H, Satomi K, Yoshida A, Sunami K, Hirata M, Shimoi T, Sudo K, Okuma HS, Yonemori K, Suzuki H, Ichimura K, Narita Y. Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas. Cancers (Basel). 2022 May 16;14(10):2454. PubMed PMID: 35626060. Pubmed Central PMCID: 9139713. doi: 10.3390/cancers14102454.
  36. Itami J, Kobayashi K, Mori T, Honma Y, Kubo Y, Murakami N, Omura G, Okuma K, Inaba K, Takahashi K, Kashihara T, Shimizu Y, Takahashi A, Nakayama Y, Matsumoto F, Yoshimoto S, Igaki H. Non-Robustness of Ang's Risk Classification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma in Japanese Patients. Cancers (Basel). 2022 May 15;14(10):2442. PubMed PMID: 35626047. Pubmed Central PMCID: 9139843. doi: 10.3390/cancers14102442.
  37. Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Kawauchi D, Kikuchi M, Igaki H, Yoshida A, Satomi K, Matsushita Y, Ichimura K, Narita Y. Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma. Radiat Oncol. 2022 May 3;17(1):85. PubMed PMID: 35505351. Pubmed Central PMCID: 9066974. doi: 10.1186/s13014-022-02054-x.
  38. Takagawa Y, Murakami N, Igaki H, Okamoto H, Itami J. High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma - a case report. J Contemp Brachytherapy. 2022 Apr;14(2):198-204. PubMed PMID: 35494187. Pubmed Central PMCID: 9044308. doi: 10.5114/jcb.2022.115161.
  39. Murakami N, Watanabe M, Uno T, Sekii S, Tsujino K, Kasamatsu T, Machitori Y, Aoshika T, Kato S, Hirowatari H, Kaneyasu Y, Nakagawa T, Ikushima H, Ando K, Murata M, Yoshida K, Yoshioka H, Murata K, Ohno T, Okonogi N, Saito A, Ichikawa M, Okuda T, Tsuchida K, Sakurai H, Yoshimura R, Yoshioka Y, Yorozu A, Okamoto H, Inaba K, Kato T, Igaki H, Itami J. Large volume was associated with increased risk of acute non-hematologic adverse events in the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical cancer: preliminary results of prospective phase I/II clinical trial. Jpn J Clin Oncol. 2022 Aug 5;52(8):859-68. PubMed PMID: 35470390. doi: 10.1093/jjco/hyac072.
  40. Murakami N, Ando K, Murata M, Murata K, Ohno T, Aoshika T, Kato S, Okonogi N, Saito AI, Kim JY, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Itami J. An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma. J Radiat Res. 2022 May 18;63(3):412-27. PubMed PMID: 35446962. Pubmed Central PMCID: 9124620. doi: 10.1093/jrr/rrac014.
  41. Hosoya T, Takahashi M, Honda-Kitahara M, Miyakita Y, Ohno M, Yanagisawa S, Omura T, Kawauchi D, Tamura Y, Kikuchi M, Nakano T, Yoshida A, Igaki H, Matsushita Y, Ichimura K, Narita Y. MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas. J Neurooncol. 2022 May;157(3):561-71. PubMed PMID: 35397757. Pubmed Central PMCID: 9072488. doi: 10.1007/s11060-022-03999-5.
  42. Murakami N, Ohno T, Toita T, Ando K, Ii N, Okamoto H, Kojima T, Tsujino K, Masui K, Yoshida K, Ikushima H. Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers. J Radiat Res. 2022 May 18;63(3):402-11. PubMed PMID: 35349700. Pubmed Central PMCID: 9124614. doi: 10.1093/jrr/rrac011.
  43. Okamoto H, Iijima K, Chiba T, Takemori M, Nakayama H, Fujii K, Kon M, Mikasa S, Nakaichi T, Urago Y, Aikawa A, Katsuta S, Nakamura S, Igaki H. Technical note: Analysis of brachytherapy source movement by high-speed camera. Med Phys. 2022 Jul;49(7):4804-11. PubMed PMID: 35279854. doi: 10.1002/mp.15601.
  44. Kawahara D, Tsuneda M, Ozawa S, Okamoto H, Nakamura M, Nishio T, Nagata Y. Deep learning-based auto segmentation using generative adversarial network on magnetic resonance images obtained for head and neck cancer patients. J Appl Clin Med Phys. 2022 May;23(5):e13579. PubMed PMID: 35263027. Pubmed Central PMCID: 9121028. doi: 10.1002/acm2.13579.
  45. Kashihara T, Urago Y, Okamoto H, Takemori M, Nakayama H, Mikasa S, Nakaichi T, Iijima K, Chiba T, Kuwahara J, Nakamura S, Chang W, Matsui Y, Igaki H. A preliminary study on rectal dose reduction associated with hyaluronic acid implantation in brachytherapy for prostate cancer. Asian Journal of Urology. 2023;In press.

2021年度

雑誌論文

  1. Takamizawa, S., Y. Honma, N. Murakami, T. Mori, H. Oka, S. Yamamoto, T. Kashihara, K. Ito, Y. Kubo, A. Ikeda, F. Matsumoto, G. Omura, K. Kobayashi, J. Itami, K. Kato and S. Yoshimoto (2021). Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma. Invest New Drugs 39(2): 564-570.
  2. Yonezawa, H., M. Ohno, H. Igaki, Y. Miyakita, M. Takahashi, Y. Tamura, S. Shima, Y. Matsushita, K. Ichimura and Y. Narita (2021). Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment. Jpn J Clin Oncol 51(7): 1028-1035.
  3. Murakami, N., T. Mori, R. Machida, T. Kodaira, Y. Ito, N. Shikama, K. Konishi, Y. Matsumoto, Y. Murakami, N. Nakamura, H. Yamashita, A. Yorozu, M. Yoshimura, K. Inoue, M. Nozaki, S. Ishikura, J. Itami, Y. Nishimura and Y. Kagami (2021). Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer. Laryngoscope 131(7): 1522-1527.
  4. Yokoyama, K., N. Murakami, A. Takahashi, K. Kobayashi, H. Igaki and J. Itami (2021). Radiation Therapy− Induced Autoeczematization. Pract Radiat Oncol 11(5): E447-E448.
  5. Murakami, N., Y. Asami, H. Yoshida, D. Takayanagi, S. Hirose, I. Kuno, K. Takahashi, M. Matsuda, Y. Shimada, S. Yamano, K. Sunami, T. Honda, T. Nakahara, T. Watanabe, K. Okuma, T. Kuroda, T. Kohno, T. Kato, K. Shiraishi and J. Itami (2021). Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy. Sci Rep 11(1): 10567.
  6. Umezawa, R., A. Wakita, Y. Katsuta, Y. Ito, S. Nakamura, H. Okamoto, N. Kadoya, K. Takahashi, K. Inaba, N. Murakami, H. Igaki, K. Jingu and J. Itami (2021). A Pilot Study of Synchronization of Respiration-Induced Motions in the Duodenum and Stomach for the Primary Tumor in Radiation Therapy for Pancreatic Cancer Using 4-Dimensional Computed Tomography. Adv Radiat Oncol 6(4): 100730.
  7. Murakami, N., K. Ando, M. Murata, K. Murata, T. Ohno, T. Aoshika, S. Kato, N. Okonogi, A. I. Saito, J. Y. Kim, Y. Kumai, Y. Yoshioka, S. Sekii, K. Tsujino, C. Lowanichkiattikul, P. Pattaranutaporn, Y. Kaneyasu, T. Nakagawa, M. Watanabe, T. Uno, R. Umezawa, K. Jingu, A. Kanemoto, M. Wakatsuki, K. Shirai, H. Igaki and J. Itami (2021). Why not de-intensification for uterine cervical cancer? Gynecol Oncol 163(1): 105-109.
  8. Murakami, N., Y. Honma, S. Yoshimoto, S. Shima, T. Kashihara, K. Takahashi, T. Kaneda, K. Inaba, K. Okuma, K. Masui, K. Yoshida, H. Igaki and J. Itami (2021). Gel spacer to protect carotid artery and reconstructed jejunum in image-guided interstitial brachytherapy for recurrent hypopharyngeal cancer: a technical report. J Contemp Brachytherapy 13(5): 583-587.
  9. Kuno, I., D. Takayanagi, Y. Asami, N. Murakami, M. Matsuda, Y. Shimada, S. Hirose, M. K. Kato, M. Komatsu, R. Hamamoto, K. Okuma, T. Kohno, J. Itami, H. Yoshida, K. Shiraishi and T. Kato (2021). TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer. Sci Rep 11(1): 19261.
  10. Nakamura, S., H. Igaki, M. Ito, S. Imamichi, T. Kashihara, H. Okamoto, S. Nishioka, K. Iijima, T. Chiba, H. Nakayama, M. Takemori, Y. Abe, T. Kaneda, K. Takahashi, K. Inaba, K. Okuma, N. Murakami, Y. Nakayama, M. Masutani, T. Nishio and J. Itami (2021). Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target. Sci Rep 11(1): 8090.
  11. Takada, M., T. Nunomiya, A. Masuda, T. Matsumoto, H. Tanaka, S. Nakamura, S. Endo, M. Nakamura, K. Aoyama, O. Ueda, M. Narita and T. Nakamura (2021). Development of a real-time neutron beam detector for boron neutron capture therapy using a thin silicon sensor. Appl Radiat Isot 176: 109856.
  12. Urago, Y., H. Okamoto, T. Kaneda, N. Murakami, T. Kashihara, M. Takemori, H. Nakayama, K. Iijima, T. Chiba, J. Kuwahara, S. Katsuta, S. Nakamura, W. Chang, H. Saitoh and H. Igaki (2021). Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models. Radiat Oncol 16(1): 175.
  13. Nakayama, H., S. Nakamura, K. Iijima, T. Chiba, M. Takemori, T. Kashihara, K. Okuma, H. Igaki, H. Saitoh, W. Chang and H. Okamoto (2021). Efficacy of tangential irradiation with volumetric modulated arc therapy on scalp angiosarcoma using medical linac. Phys Med 91: 105-116.
  14. Iijima, K., H. Okamoto, S. Nishioka, T. Sakasai, S. Nakamura, T. Chiba, K. Kaga, M. Takemori, H. Nakayama, Y. Miura, D. Fujiyama, Y. Tsunoda, H. Igaki, S. Katsuta and J. Itami (2021). Performance of a newly designed end-to-end phantom compatible with magnetic resonance-guided radiotherapy systems. Med Phys 48(11): 7541-7551.
  15. Ishiyama, H., H. Tsumura, H. Nagano, M. Watanabe, E. Mizuno, M. Taka, H. Kobayashi, T. Eriguchi, H. Imada, K. Inaba and K. Nakamura (2021). Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients. Sci Rep 11(1): 13194.
  16. Inaba, K., K. Tsuchida, T. Kashihara, R. Umezawa, K. Takahashi, K. Okuma, N. Murakami, Y. Ito, H. Igaki, M. Sumi, Y. Nakayama, Y. Shinoda, T. Hara, Y. Matsui, M. Komiyama, H. Fujimoto and J. Itami (2021). Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer. J Radiat Res 62(3): 511-516.
  17. Takamizawa, S., Y. Honma, N. Murakami, T. Mori, H. Oka, S. Yamamoto, T. Kashihara, K. Ito, Y. Kubo, A. Ikeda, F. Matsumoto, G. Omura, K. Kobayashi, J. Itami, K. Kato and S. Yoshimoto (2021). Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma. Invest New Drugs 39(2): 564-570.
  18. Kashihara, T., S. Nakamura, N. Murakami, K. Ito, Y. Matsumoto, K. Kobayashi, G. Omura, T. Mori, Y. Honma, Y. Kubo, H. Okamoto, K. Takahashi, K. Inaba, K. Okuma, H. Igaki, Y. Nakayama, K. Kato, F. Matsumoto, S. Yoshimoto and J. Itami (2021). Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases >/= 2 cm in Patients With Head and Neck Squamous Cell Carcinoma. Front Oncol 11: 651409.
  19. Kashihara, T. and K. Kashihara (2021). Radiotherapy with genomic-adjusted radiation dose. Lancet Oncol 22(11): e468.
  20. Kashihara, T. (2021). SABR for operable stage I non-small-cell lung cancer: comparison to surgery. Lancet Oncol 22(12): e534.
  21. Kashihara, T. and K. Kashihara (2021). Lutetium-177-PSMA-617 for Prostate Cancer. N Engl J Med 385(26): 2494-2495.
  22. Kadoya, N., S. Sakulsingharoj, T. Kron, A. Yao, N. Hardcastle, A. Bergman, H. Okamoto, N. Mukumoto, Y. Nakajima, K. Jingu and M. Nakamura (2021). Development of a physical geometric phantom for deformable image registration credentialing of radiotherapy centers for a clinical trial. J Appl Clin Med Phys 22(7): 255-265.
  23. Chen, L., S. Imamichi, Y. Tong, Y. Sasaki, T. Onodera, S. Nakamura, H. Igaki, J. Itami and M. Masutani (2021). A Combination of GM-CSF and Released Factors from Gamma-Irradiated Tumor Cells Enhances the Differentiation of Macrophages from Bone Marrow Cells and Their Antigen-Presenting Function and Polarization to Type 1. Medicines (Basel) 8(7): 35.
  24. Kitaguchi, M., H. Yamashita, R. Takenaka, K. Okuma, K. Nawa and K. Nakagawa (2021). Helical Skin Radiation Therapy Including Total Skin Radiation Therapy Using Tomotherapy for Primary Cutaneous Lymphoma With Bone Marrow Suppression as a Related Adverse Event. Pract Radiat Oncol 11(3): e308-e321.
  25. Igaki, H., N. Murakami, S. Nakamura, N. Yamazaki, T. Kashihara, A. Takahashi, K. Namikawa, M. Takemori, H. Okamoto, K. Iijima, T. Chiba, H. Nakayama, A. Takahashi, T. Kaneda, K. Takahashi, K. Inaba, K. Okuma, Y. Nakayama, K. Shimada, H. Nakagama and J. Itami (2022). Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients. Clin Transl Radiat Oncol 33: 128-133.
  26. Murakami, N., K. Okuma, H. Okamoto, S. Nakamura, T. Kashihara, T. Kaneda, K. Takahashi, K. Inaba, H. Igaki, K. Masui, K. Yoshida, T. Kato and J. Itami (2022). Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies. J Contemp Brachytherapy 14(1): 52-59.
  27. Murakami, N., I. Kuno, H. Yoshida, K. Shiraishi, T. Kato and H. Igaki (2022). How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment? J Radiat Res 63(2): 312-313.
  28. Akiyama, H., K. Yoshida, T. Takenaka, T. Kotsuma, K. Masui, H. Monzen, I. Sumida, Y. Tsujimoto, M. Miyao, H. Okumura, T. Shimbo, H. Takegawa, N. Murakami, K. Inaba, T. Kashihara, Z. Takacsi-Nagy, N. Tselis, H. Yamazaki, E. Tanaka, K. Nihei and Y. Ariji (2022). Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity. J Contemp Brachytherapy 14(1): 87-95.
  29. Nakamura, S., N. Murakami, S. Suzuki, K. Ito, M. Takemori, H. Nakayama, K. Kaga, T. Chiba, K. Iijima, K. Takahashi, T. Goka, J. Itami, H. Okamoto and H. Igaki (2022). Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma. Radiat Oncol 17(1): 16.
  30. Okamoto, H., K. Okuma, H. Nakayama, S. Nakamura, K. Iijima, T. Chiba, M. Takemori, K. Fujii, S. Mikasa, T. Nakaichi, A. Aikawa, S. Katsuta and H. Igaki (2022). In vivo dosimetry for testicular and scalp shielding in total skin electron therapy using a radiophotoluminescence glass dosimeter. J Radiat Res 63(1): 51-54.
  31. Tamura, Y., K. Demachi, H. Igaki, H. Okamoto and M. Nakano (2022). A Real-Time Four-Dimensional Reconstruction Algorithm of Cine-Magnetic Resonance Imaging (Cine-MRI) Using Deep Learning. Cureus 14(3): e22826.
  32. Murakami, N., T. Ohno, T. Toita, K. Ando, N. Ii, H. Okamoto, T. Kojima, K. Tsujino, K. Masui, K. Yoshida and H. Ikushima (2022). Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers. J Radiat Res 63(3): 402-411.
  33. Okamoto, H., K. Iijima, T. Chiba, M. Takemori, H. Nakayam, K. Fujii, M. Kon, S. Mikasa, T. Nakaichi, Y. Urago, A. Aikawa, S. Katsuta, S. Nakamura and H. Igaki (2022). Technical note: Analysis of brachytherapy source movement by high-speed camera. Med Phys 49(7): 4804-4811.
  34. Kashihara, T., H. Ishiki and K. Kato (2022). Definitive Chemoradiotherapy for Older Patients With Esophageal Cancer. JAMA Oncol 8(2): 304-305.
  35. Kawahara, D., M. Tsuneda, S. Ozawa, H. Okamoto, M. Nakamura, T. Nishio, A. Saito and Y. Nagata (2022). Stepwise deep neural network (stepwise-net) for head and neck auto-segmentation on CT images. Comput Biol Med 143: 105295.
  36. Imamichi, S., L. Chen, T. Ito, Y. Tong, T. Onodera, Y. Sasaki, S. Nakamura, P. Mauri, Y. Sanada, H. Igaki, Y. Murakami, M. Suzuki, J. Itami, S. Masunaga and M. Masutani (2022). Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology (Basel) 11(3): 420.
  37. Kawahara, D., M. Tsuneda, S. Ozawa, H. Okamoto, M. Nakamura, T. Nishio and Y. Nagata (2022). Deep learning-based auto segmentation using generative adversarial network on magnetic resonance images obtained for head and neck cancer patients. J Appl Clin Med Phys 23(5): e13579.

2020年度

雑誌論文

  1. Yokomichi, H., T. Inozume, M. Wada, J. Asai, H. Igaki, K. Namikawa, A. Hayashi, S. Fukushima, T. Fujimura, H. Koga, Y. Nakamura, M. Mochizuki and Z. Yamagata (2020). Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)(V600E) Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis. JMA J 3(3): 274-279.
  2. Umezawa, R., Y. Ito, A. Wakita, S. Nakamura, H. Okamoto, K. Takahashi, K. Inaba, N. Murakami, H. Igaki, K. Jingu and J. Itami (2020). How Much Was the Elective Lymph Node Region Covered in Involved-Field Radiation Therapy for Locally Advanced Pancreatic Cancer? Evaluation of Overlap Between Gross Target Volume and Celiac Artery-Superior Mesenteric Artery Lymph Node Regions. Adv Radiat Oncol 5(3): 377-387.
  3. Tsuchida, K., K. Inaba, T. Kashihara, N. Murakami, K. Okuma, K. Takahashi, H. Igaki, Y. Nakayama, A. Maejima, Y. Shinoda, Y. Matsui, M. Komiyama, H. Fujimoto, Y. Ito, M. Sumi, T. Nakano and J. Itami (2020). Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer. Cancer Med 9(18): 6629-6637.
  4. Takada, M., T. Nunomiya, A. Masuda, T. Matsumoto, H. Tanaka, S. Nakamura, S. Endo, M. Nakamura, K. Aoyama and O. Ueda (2020). Characterization of a real-time neutron detector for boron neutron capture therapy using a thin silicon diode. Radiation Measurements 137: 106381.
  5. Sonoda, Y., Y. Sasaki, A. Gunji, H. Shirai, T. Araki, S. Imamichi, T. Onodera, A. M. Ryden, M. Watanabe, J. Itami, T. Honda, K. Ashizawa, K. Nakao and M. Masutani (2020). Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under Parg Deficiency. Cancers (Basel) 12(4).
  6. Shoji, M., K. Inaba, J. Itami, M. Hamada, H. Okamoto, T. Iwasa, T. Ushigusa, M. Yoshida, T. A. Matsuyama, T. Otsuka, K. Kumagai, K. Hirao, P. Maguire, P. Qian, E. Gardner and P. C. Zei (2020). Advantages and challenges for noninvasive atrial fibrillation ablation. J Interv Card Electrophysiol.
  7. Nishio, T., M. Nakamura, H. Okamoto, S. Kito, T. Minemura, S. Ozawa, Y. Kumazaki, M. Ishikawa, N. Tohyama, M. Kurooka, T. Nakashima, H. Shimizu, R. Suzuki, S. Ishikura and Y. Nishimura (2020). An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group. J Radiat Res 61(6): 999-1008.
  8. Nakata, M., K. Yoshida, T. Shimbo, N. Yoshikawa, H. Yoshioka, A. Hori, C. Sato, Y. Uesugi, Y. Kogata, K. Masui, N. Murakami, T. Kashihara, H. Akiyama, N. Tselis, M. Ohmichi and K. Nihei (2020). High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report. J Contemp Brachytherapy 12(6): 606-611.
  9. Murakami, N., S. Yoshimoto, M. Uematsu, T. Kashihara, K. Takahashi, K. Inaba, K. Okuma, H. Igaki, Y. Nakayama, K. Masui, K. Yoshida and J. Itami (2020). Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx. BJR Case Rep 6(4): 20200005.
  10. Murakami, N., T. Mori, R. Machida, T. Kodaira, Y. Ito, N. Shikama, K. Konishi, Y. Matsumoto, Y. Murakami, N. Nakamura, H. Yamashita, A. Yorozu, M. Yoshimura, K. Inoue, M. Nozaki, S. Ishikura, J. Itami, Y. Nishimura and Y. Kagami (2020). Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer. Laryngoscope.
  11. Murakami, N., H. Igaki, H. Okamoto, T. Kashihara, T. Kaneda, K. Takahashi, K. Inaba, K. Okuma and J. Itami (2020). Preparation for the COVID-19 pandemic in the department of radiation oncology in the National Cancer Center Hospital in Tokyo. J Radiat Res 61(4): 635-637.
  12. Murakami, N., G. Cheng, S. Yoshimoto and J. Itami (2020). Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects. J Contemp Brachytherapy 12(3): 294-302.
  13. Masui, K., H. Yamazaki, G. Suzuki, D. Shimizu, K. Kawabata, N. Noguchi, T. Takenaka, K. Yoshida, N. Murakami, M. Naito, T. Yamamoto, N. Kanamura, S. Komori, A. Oshita, J. Asai and K. Yamada (2020). High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer. J Radiat Res 61(3): 506-510.
  14. Kashihara, T., K. Kobayashi, K. Iijima, N. Murakami, K. Yoshida, K. Okuma, S. Nakamura, K. Takahashi, K. Inaba, H. Igaki, Y. Nakayama, T. Kato, T. Uno and J. Itami (2020). A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with intentional internal high-dose policy high-dose-rate interstitial brachytherapy. Medicine (Baltimore) 99(27): e20860.
  15. Kashihara, T., K. Inaba, M. Komiyama, H. Nakayama, K. Iijima, S. Nishioka, H. Okamoto, N. Kikkawa, Y. Kubo, S. Shima, S. Nakamura, A. Takahashi, K. Takahashi, K. Okuma, N. Murakami, H. Igaki, Y. Nakayama, A. Fukunaga, Y. Matsui, H. Fujimoto and J. Itami (2020). The use of hyperbaric oxygen to treat actinic rectal fistula after SpaceOAR use and radiotherapy for prostate cancer: a case report. BMC Urol 20(1): 196.
  16. Karube, M., N. Murakami, H. Okamoto, K. Okuma, T. Kashihara, K. Takahashi, T. Kaneda, K. Inaba, H. Igaki, T. Kato and J. Itami (2020). Transvaginal artificial ascites infusion as a spacer in gynecological brachytherapy: a novel technique. J Contemp Brachytherapy 12(5): 487-491.
  17. Kajikawa, T., N. Kadoya, S. Tanaka, H. Nemoto, N. Takahashi, T. Chiba, K. Ito, Y. Katsuta, S. Dobashi, K. Takeda, K. Yamada and K. Jingu (2020). Dose distribution correction for the influence of magnetic field using a deep convolutional neural network for online MR-guided adaptive radiotherapy. Phys Med 80: 186-192.
  18. Itami, J. (2020). Modern development of high-dose-rate brachytherapy. Jpn J Clin Oncol 50(5): 490-501.
  19. Bei, Y., N. Murakami, Y. Nakayama, K. Okuma, T. Kashihara, V. P. Raturi, H. Okamoto, K. Takahashi, K. Inaba, H. Igaki and J. Itami (2020). Stereotactic body radiation therapy for early-stage non-small-cell lung cancer in octogenarians and older: an alternative treatment. J Radiat Res 61(4): 586-593.
  20. Murakami, N., G. Omura, W. Yatsuoka, H. Okamoto, S. Yoshimoto, T. Ueno and J. Itami (2021). Hybrid Intracavitary-Interstitial brachytherapy in a case of nasal vestibule cancer penetrating the hard palate. BJR Case Rep 7(4): 20200178.
  21. Yogo, K., Y. Noguchi, K. Okudaira, M. Nozawa, H. Ishiyama, H. Okamoto, H. Yasuda, H. Oguchi and S. Yamamoto (2021). Source position measurement by Cherenkov emission imaging from applicators for high-dose-rate brachytherapy. Med Phys 48(1): 488-499.
  22. Takayanagi, D., S. Hirose, I. Kuno, Y. Asami, N. Murakami, M. Matsuda, Y. Shimada, K. Sunami, M. Komatsu, R. Hamamoto, M. K. Kato, K. Matsumoto, T. Kohno, T. Kato, K. Shiraishi and H. Yoshida (2021). Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix. Cancers (Basel) 13(6).
  23. Okamoto, H., S. Kito, N. Tohyama, S. Yonai, R. Kawamorita, M. Nakamura, T. Fujimoto, S. Tani, A. Yomoda, T. Isobe, H. Furukawa, K. Kotaka, J. Itami, H. Ikushima, T. Dokiya and Y. Shioyama (2021). Radiation protection in radiological imaging: a survey of imaging modalities used in Japanese institutions for verifying applicator placements in high-dose-rate brachytherapy. J Radiat Res 62(1): 58-66.
  24. Murakami, N., S. Nakamura, T. Kashihara, K. Inaba, T. Kaneda, K. Takahashi, K. Okuma, H. Igaki and J. Itami (2021). Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic. Radiother Oncol 154: 274-275.
  25. Kobayashi, K., S. Yoshimoto, M. Ando, F. Matsumoto, N. Murakami, G. Omura, Y. Honma, Y. Matsumoto, A. Ikeda, A. Sakai, K. Eguchi, A. Ito, E. Ryo, Y. Yatabe and T. Mori (2021). Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence. Oral Oncol 113: 105091.
  26. Kobayashi, K., N. Murakami, K. Takahashi, K. Inaba, H. Igaki, R. Hamamoto and J. Itami (2021). Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer. In Vivo 35(1): 489-497.
  27. Kashihara, T., Y. Nakayama, K. Ito, Y. Kubo, K. Okuma, S. Shima, S. Nakamura, K. Takahashi, K. Inaba, N. Murakami, H. Igaki, Y. Ohe, M. Kusumoto and J. Itami (2021). Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer. Adv Radiat Oncol 6(1): 100606.
  28. Iijima, K., N. Murakami, H. Okamoto, S. Nakamura, S. Nishioka, T. Chiba, J. Kuwahara, H. Nakayama, M. Takemori, A. Aikawa, S. Yoshihiro, T. Kashihara, K. Takahashi, K. Inaba, K. Okuma, H. Igaki, Y. Nakayama and J. Itami (2021). A dosimetric and centeredness comparison of the conventional and novel endobronchial applicators: A preliminary study. Brachytherapy 20(2): 467-477.
  29. Iijima, K., N. Murakami, S. Nakamura, S. Nishioka, T. Chiba, J. Kuwahara, M. Takemori, H. Nakayama, T. Kashihara, K. Okuma, K. Takahashi, K. Inaba, H. Igaki, H. Okamoto and J. Itami (2021). Configuration analysis of the injection position and shape of the gel spacer in gynecologic brachytherapy. Brachytherapy 20(1): 95-103.
  30. Fujimoto, T., M. Suzuki, S. Kuratsu, I. Fujita, M. Morishita, T. Sudo, T. Sakuma, Y. Nakamatsu, Y. Sakurai, T. Takata, Y. Tamari, H. Tanaka, S. I. Masunaga, Y. Kinashi, N. Kondo, S. Sakakibara, H. Igaki, T. Andoh, S. Sakamoto, T. Kawamoto, T. Watabe, H. Hara, N. Fukase, Y. Kawakami, T. Matsumoto, T. Akisue, K. Ono, H. Ichikawa, R. Kuroda and T. Hirose (2021). BNCT for primary synovial sarcoma. Appl Radiat Isot 169: 109407.
  31. Itami, J., N. Murakami, M. Watanabe, S. Sekii, T. Kasamatsu, S. Kato, H. Hirowatari, H. Ikushima, K. Ando, T. Ohno, H. Okamoto, K. Okuma and H. Igaki (2021). Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer. Front Oncol 11: 809825.
  32. Murakami, N., S. Nakamura, T. Kashihara, K. Inaba, T. Kaneda, K. Takahashi, K. Okuma, H. Igaki and J. Itami (2021). Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the COVID-19 pandemic. Radiother Oncol 154: 274-275.
  33. Kobayashi, K., N. Murakami, K. Takahashi, K. Inaba, H. Igaki, R. Hamamoto and J. Itami (2021). Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer. In Vivo 35(1): 489-497.
  34. Takayanagi, D., S. Hirose, I. Kuno, Y. Asami, N. Murakami, M. Matsuda, Y. Shimada, K. Sunami, M. Komatsu, R. Hamamoto, M. K. Kato, K. Matsumoto, T. Kohno, T. Kato, K. Shiraishi and H. Yoshida (2021). Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix. Cancers (Basel) 13(6): 1215.
  35. Shimizu, Y., N. Murakami, T. Chiba, T. Kaneda, H. Okamoto, S. Nakamura, A. Takahashi, T. Kashihara, K. Takahashi, K. Inaba, K. Okuma, Y. Nakayama, J. Itami and H. Igaki (2021). High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note. Front Oncol 11: 808721.
  36. Watase, C., S. Shiino, T. Shimoi, E. Noguchi, T. Kaneda, Y. Yamamoto, K. Yonemori, S. Takayama and A. Suto (2021). Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives. Cancers (Basel) 13(5): 1078.
  37. Su, C., H. Okamoto, S. Nishioka, T. Sakasai, D. Fujiyama, Y. Miura, Y. Tsunoda, J. Kuwahara, S. Nakamura, K. Iijima, T. Chiba, K. Kaga, M. Takemori, H. Nakayama, S. Katsuta, K. Inaba, H. Igaki, Y. Nakayama and J. Itami (2021). Dosimetric effect of the intestinal gas of online adaptive stereotactic body radiotherapy on target and critical organs without online electron density correction for pancreatic cancer. Br J Radiol 94(1119): 20200239.

2019年度以前

雑誌論文

  1. Yoshida, K., T. Kotsuma, H. Akiyama, H. Yamazaki, T. Takenaka, K. Masui, Y. Tsujimoto, N. Murakami, Y. Uesugi, T. Shimbo, N. Yoshikawa, H. Yoshioka, M. Nakata, T. Arika, Y. Takaoka, E. Tanaka and N. Tselis (2019). A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer. J Contemp Brachytherapy 11(6): 573-578.
  2. Kashihara, T., N. Murakami, N. Tselis, K. Kobayashi, K. Tsuchida, S. Shima, K. Masui, K. Yoshida, K. Takahashi, K. Inaba, R. Umezawa, H. Igaki, Y. Ito, T. Kato, T. Uno and J. Itami (2019). Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience. J Radiat Res 60(4): 501-508.
  3. Hirose, S., N. Murakami, K. Takahashi, I. Kuno, D. Takayanagi, Y. Asami, M. Matsuda, Y. Shimada, S. Yamano, K. Sunami, K. Yoshida, T. Honda, T. Nakahara, T. Watanabe, M. Komatsu, R. Hamamoto, M. K. Kato, K. Matsumoto, K. Okuma, T. Kuroda, A. Okamoto, J. Itami, T. Kohno, T. Kato, K. Shiraishi and H. Yoshida (2020). Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients. Gynecol Oncol 156(1): 203-210.
  4. Honma, Y., K. Nagashima, H. Hirano, H. Shoji, S. Iwasa, A. Takashima, N. Okita, K. Kato, N. Boku, N. Murakami, K. Inaba, Y. Ito, J. Itami, J. Kanamori, J. Oguma and H. Daiko (2020). Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy. Cancer Med 9(2): 595-604.
  5. Igaki, H., S. Nakamura, H. Kurihara, Y. Abe, S. Nishioka, R. Fujii, M. Nakamura, Y. Nakayama, T. Morita, H. Okamoto, Y. Imahori and J. Itami (2020). Comparison of (18)FBPA uptake with (18)FDG uptake in cancer patients. Appl Radiat Isot 157: 109019.
  6. Murakami, N., T. Mori, Y. Kubo, S. Yoshimoto, K. Ito, Y. Honma, T. Ueno, K. Kobayashi, H. Okamoto, N. Boku, K. Takahashi, K. Inaba, K. Okuma, H. Igaki, Y. Nakayama and J. Itami (2020). Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients. J Radiat Res 61(1): 161-168.
  7. Murakami, N., S. Nakamura, T. Kashihara, T. Kato, Y. Shibata, K. Takahashi, K. Inaba, K. Okuma, H. Igaki, Y. Nakayama, R. Galalae and J. Itami (2020). Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies. Brachytherapy 19(2): 154-161.
  8. Murakami N, Yoshimoto S, Nakamura S, Uematsu M, Kashihara T, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, and Itami J. Per-oral interstitial brachytherapy catheter insertion for boost in case of recurrent tonsillar carcinoma: dosimetry and clinical outcome. BJR. Case Rep. 6(1): 20190059 (2020)
  9. Nozaki, T., K. Nakamoto, A. B. Myat, Y. Sasaki, S. Imamichi, T. Onodera and M. Masutani (2020). Effects of 3-aminobenzamide on cell cycle arrest after gamma-irradiation. J Transl Sci 6(1): 1-6.
  10. Ohtsuka, M., T. Hamada, T. Miyagaki, T. Shimauchi, K. Yonekura, E. Kiyohara, H. Fujita, K. Izutsu, K. Okuma, K. Kawai, H. Koga and M. Sugaya (2021). Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020. J Dermatol 48(2): e49-e71.
  11. Iijima K,Okamoto H,Takahashi K,Aikawa A,Wakita A,Nakamura S, Nishioka S, Harada K, Notake R, Yoshimura R, Kunieda E,and Itami J, Inter-fractional variations in the dosimetric parameters of accelerated partial breast irradiation using a strut-adjusted volume implant, J Radiat Res, 61(1):123-133, 2020.
  12. Okamoto H, Murakami N, Isohashi I, Kasamatsu T, Hasumi Y, Iijima K, Nishioka S, Nakamura S, Nakamura M, Nishio T, Igaki H, Nakayama Y, Itami J, Ishikura S, Nishimura Y, Toita T, Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402), Radiat Oncol. 2019, 14(1), 133.
  13. Murakami N, Isohashi F, Hasumi Y, Kasamatsu T, Okamoto H, Nakamura K, Shibata T, Ito Y, Ishikura S, Nishimura Y, Yaegashi N, Toita T, Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer:Japan, Jpn J Clin Oncol, 49(9):881-885, 2019.
  14. Okamoto H, Nishioka S, Iijima K, Nakamura S, Sakasai T, Miura Y, Takemori M, Nakayama H, Morishita Y, Shimizu M, Abe Y, Igaki H, Nakayama Y, Itami J.Monte Carlo modeling of a 60Co MRI-guided radiotherapy system on Geant4 and experimental verification of dose calculation under a magnetic field of 0.35 T. J Radiat Res. 2019 ;60(1):116-123.
  15. Nakamura S, Igaki H, Okamoto H, Wakita A, Ito M, Imamichi S, Nishioka S, Iijima K, Nakayama H, Takemori M, Kobayashi K, Abe Y, Okuma K, Takahashi K, Inaba K, Murakami N, Nakayama Y, Nishio T, Masutani M, Itami J. Dependence of neutrons generated by 7Li(p,n) reaction on Li thickness under free-air condition in accelerator-based boron neutron capture therapy system employing solid-state Li target. Phys Med. 2019 ;58:121-130.
  16. Kashihara T, Murakami N, Iizumi S, Sakamoto Y, Nakamura S, Iijima K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Okusaka T, Uno T, Itami J. Hemorrhage from Ascending Colon and Gluteal Muscle Associated with Sorafenib and Radiotherapy: Radiation Dose Distribution Corresponded with Colonoscopy Findings and Computed Tomography Images. Pract Radiat Oncol. 2019 Feb 27. pii: S1879-8500(19)30066-9.
  17. Tsuchida K, Murakami N, Kato T, Okuma K, Okamoto H, Kashihara T, Takahashi K, Inaba K, Igaki H, Nakayama Y, Nakano T, Itami J, Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients, J Radiat Res, 60(5), 2019, 650–657.
  18. Nakamura S, Igaki H, Ito M, Okamoto H, Nishioka S, Iijima K, Nakayama H, Takemori M, Imamichi S, Kashihara T, Takahashi K, Inaba K, Okuma K, Murakami N, Abe Y, Nakayama Y, Masutani M, Nishio T, and Itami J. Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target. PLoS One, PLoS One. 14(11):e0225587, 2019.
  19. Murakami N, Mori T, Nakamura S, Yoshimoto S, Honma Y, Ueno T, Kobayashi K, Kashihara T, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, and Itami J. Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy. J. Radiat. Res.60(6):803-811, 2019.
  20. Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, and Itami J. Dose escalation of external beam radiotherapy for high-risk prostate cancer-Impact of multiple high-risk factor. Asian J. Urol. 6(2), 192-199, 2019.
  21. Okamoto H, Minemura T, Nakamura M, Mizuno H, Tohyama N, Nishio T, Wakita A, Nakamura S, Nishioka S, Iijima K, Fujiyama D, Itami J, Nishimura Y. Establishment of postal audit system in intensity-modulated radiotherapy by radiophotoluminescent glass dosimeters and a radiochromic film.Phys Med. 2018;48:119-126.
  22. Kashihara T, Nakamura S, Wakita A, Okamoto H, Inaba K, Umezawa R, Shima S, Tsuchida K, Kobayashi K, Takahashi K, Murakami N, Ito Y, Igaki H, Fujimoto H, Uno T, Itami J.Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.Cancer Med. 2018;7(5):1723-1730.
  23. Umezawa R, Murakami N, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Inaba K, Ito Y, Igaki H, Masui K, Yoshida K, Jingu K, Tselis N, Itami J. Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: A single-institution study.Brachytherapy. 2018;17(2):368-376.
  24. Umezawa R, Inaba K, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Takahashi K, Murakami N, Ito Y, Igaki H, Jingu K, Itami J.Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis.Anticancer Res. 2018;38(4):2303-2309.
  25. Murakami N, Ueno T, Yatsuoka W, Okamoto H1, Tselis N, Masui K, Yoshida K, Takahashi K, Inaba K, Okuma K, Igaki H, Nakayama Y, Itam J. Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa.J Contemp Brachytherapy. 2018;10(5):486-491.
  26. Yoshimoto Y, Honda N, Kurihara H, Hiroi K, Nakamura S, Ito M, Shikano N, Itami J, Fujii H. Non-invasive estimation of BPA-derived boron concentration in tumors by 18F-FBPA PET. Cancer Sci. 2018; 109: 1617-1626.
  27. Okamoto H, Murakami N, Carvajal CC, Miura Y, Wakita A, Nakamura S, Nishioka S, Iijima K, Inaba K, Ito Y, Kato T, Toita T, Itami J, Positional uncertainty of vaginal cuff and feasibility of implementing portable bladder scanner in postoperative cervical cancer patients. Phys Med. 2018;45:1-5.
  28. Okamoto H, Nakamura S, Nishioka S, Iijima K, Wakita A, Abe Y, Tohyama N, Kawamura S, Minemura T, Itami J. Independent assessment of source position for gynecological applicator in high-dose-rate brachytherapy, J contemp Brachytherapy, 2017;9(5):477-486.
  29. Nakamura S, Wakita A, Ito M, Okamoto H, Nishioka S, Iijima K, Kobayashi K, Nishio T, Igaki H, Itami J. Modeling the detection efficiency of an HP-Ge detector for use in boron neutron capture therapy. Appl. Radiat. Isot. 2017; 125: 80-85.
  30. Nakamura S, Imamichi S, Masumoto K, Ito M, Wakita A, Okamoto H, Nishioka S, Iijima K, Kobayashi K, Abe Y, Igaki H, Kurita K, Nishio T, Masutani M, Itami J. Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system. 2017; 93(10): 821-831.
  31. Nakamura S, Okamoto H, Wakita A, Umezawa R, Takahashi K, Inaba K, Murakami N, Kato T, Igaki H, Ito Y, Abe Y, Itami J. A management method for the statistical results of patient-specific quality assurance for intensity-modulated radiation therapy. J Radiat Res. 2016 Nov 10.
  32. Murakami N, Kobayashi K, Kato T, Nakamura S, Wakita A, Okamoto H, Shima S, Tsuchida K, Kashihara T, Harada K, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J. The role of interstitial brachytherapy in the management of primary radiation therapy for uterine cervical cancer. J Contemp Brachytherapy. 2016 Oct;8(5):391-398.
  33. Kobayashi K, Matsumoto F, Kodaira M, Mori T, Murakami N, Yoshida A, Maki D, Teshima M, Fukasawa M, Itami J, Asai M, Yoshimoto S. Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma. Cancer Med. 2016 Oct;5(10):2708-2714.
  34. Nose T, Otani Y, Asahi S, Tsukiyama I, Dokiya T, Saeki T, Fukuda I, Sekine H, Shikama N, Kumazaki Y, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M. A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months. Breast Cancer. 2016 Nov;23(6):861-868.
  35. Kawajiri A, Maruyama D, Maeshima AM, Nomoto J, Makita S, Kitahara H, Miyamoto KI, Fukuhara S, Suzuki T, Munakata W, Tajima K, Itami J, Taniguchi H, Kobayashi Y, Tobinai K. Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era. Blood Cancer J. 2016 Sep 30;6(9):e477.
  36. Takahashi K, Morota M, Kagami Y, Okamoto H, Sekii S, Inaba K, Murakami N, Igaki H, Ito Y, Uno T, Itami J. Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom. BMC Cancer. 2016 Sep 29;16(1):757.
  37. Okamoto H, Wakita A, Nakamura S, Nishioka S, Aikawa A, Kato T, Abe Y, Kobayashi K, Inaba K, Murakami N, Itami J. Dosimetric impact of an air passage on intraluminal brachytherapy for bronchus cancer. J Radiat Res. 2016 Sep 7.
  38. Murakami N, Kato S, Nakano T, Uno T, Yamanaka T, Sakurai H, Yoshimura R, Hiratsuka J, Kuroda Y, Yoshio K, Itami J. A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer. BMC Cancer. 2016 Aug 17;16:640. doi: 10.1186/s12885-016-2543-3.
  39. Kobayashi K, Kurihara H, Watanabe Y, Murakami N, Inaba K, Nakamura S, Wakita A, Okamoto H, Umezawa R, Takahashi K, Igaki H, Ito Y, Yoshimoto S, Shigematsu N, Itami J. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer. Appl Radiat Isot. 2016 Sep;115:138-46. doi: 10.1016/j.apradiso.2016.05.026.
  40. Inaba K, Okamoto H, Wakita A, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Murakami N, Ito Y, Igaki H, Uno T, Itami J. Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy. Radiother Oncol. 2016 Jul;120(1):145-9. doi: 10.1016/j.radonc.2016.04.022.
  41. Kobayashi K, Murakami N, Inaba K, Wakita A, Nakamura S, Okamoto H, Sato J, Umezawa R, Takahashi K, Igaki H, Ito Y, Shigematsu N, Itami J. Dose reconstruction technique using non-rigid registration to evaluate spatial correspondence between high-dose region and late radiation toxicity: a case of tracheobronchial stenosis after external beam radiotherapy combined with endotracheal brachytherapy for tracheal cancer. J Contemp Brachytherapy. 2016 Apr;8(2):156-63. doi: 10.5114/jcb.2016.59688.
  42. Nakamura S, Murakami N, Inaba K, Wakita A, Kobayashi K, Takahashi K, Okamoto H, Umezawa R, Morota M, Sumi M, Igaki H, Ito Y, Itami J. After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer. BMC Cancer. 2016 May 3;16:296. doi: 10.1186/s12885-016-2329-7.
  43. Murakami N, Kato T, Miyamoto Y, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy. Anticancer Res. 2016 May;36(5):2413-21.
  44. Okamoto H, Hamada M, Sakamoto E, Wakita A, Nakamura S, Kato T, Abe Y, Takahashi K, Igaki H, Itami J. Log-file analysis of accuracy of beam localization for brain tumor treatment by CyberKnife. Pract Radiat Oncol. 2016 Jan 26. pii: S1879-8500(16)00010-2. doi: 10.1016/j.prro.2016.01.008.
  45. Murakami N, Matsumoto F, Yoshimoto S, Ito Y, Mori T, Ueno T, Tuchida K, Kashihara T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Umezawa R, Takahashi K, Inaba K, Igaki H, Itami J. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma. BMC Cancer. 2016 Mar 7;16:192. doi: 10.1186/s12885-016-2229-x.
  46. Watanabe T, Ueno H, Watabe Y, Hiraoka N, Morizane C, Itami J, Okusaka T, Miura N, Kakizaki T, Kakuya T, Kamita M, Tsuchida A, Nagakawa Y, Wilber H, Yamada T, Honda K. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer. Br J Cancer 2015;112:704-13.
  47. Murakami N, Okamoto H, Isohashi F, Murofushi K, Ohno T, Yoshida D, Saito M, Inaba K, Ito Y, Toita T, Itami J: A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan. J Radiat Res 2015 Jul;56(4):735-41. doi: 10.1093/jrr/rrv020.
  48. Murakami N, Kobayashi K, Nakamura S, Wakita A, Okamoto H, Tsuchida K, Kashihara T, Harada K, Yamada M, Sekii S, Takahashi K, Umezawa R, Inaba K, Ito Y, Igaki H, Itami J: A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy. J Contemp Brachytherapy 2015 Oct;7(5):363-8. doi: 10.5114/jcb.2015.54968. Epub 2015 Oct 13.
  49. Kobayashi K, Murakami N, Wakita A, Nakamura S, Okamoto H, Umezawa R, Takahashi K, Inaba K, Igaki H, Ito Y, Shigematsu N, Itami J: Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy. Radiother Oncol 2015 Aug 24. pii: S0167-8140(15)00442-9. doi: 10.1016/j.radonc.2015.08.017
  50. Sato A, Itoh T, Imamichi S, Kikuhara S, Fujimori H, Hirai T, Saito S, Sakurai Y, Tanaka H, Nakamura H, Suzuki M, Murakami Y, Baiseitov D, Berikkhanova K, Zhumadilov Z, Imahori Y, Itami J, Ono K, Masunaga S, Masutani M: Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells. Appl Radiat Isot 2015 Dec;106:213-9. doi: 10.1016/j.apradiso.2015.08.001.
  51. Murakami N, Kühnel A, Schmid TE, Ilicic K, Stangl S, Braun IS, Gehrmann M, Molls M, Itami J, Multhoff G: Role of membrane Hsp70 in radiation sensitivity of tumor cells. Radiat Oncol 2015 Jul 22;10:149. doi: 10.1186/s13014-015-0461-1.
  52. Watanabe H, Maehara Y, Fujibuchi T, Koizumi M, Yamaguchi I, Kida T, Ooyama M, Horitsugi G, Hiraki H, Tsukamoto A, Itami J: Assessing the Effectiveness of Risk Communication for Maintenance Workers Who Deal With Induced Radioactivity Management of Medical Linear Accelerators. Health Phys 2015 Aug;109(2):145-56. doi: 10.1097/HP.0000000000000306. Erratum in: Health Phys. 2015 Oct;109(4):330.
  53. Otani Y, Nose T, Dokiya T, Saeki T, Kumazaki Y, Asahi S, Tsukiyama I, Fukuda I, Sekine H, Shikama N, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Yoden E, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M: A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance. Radiat Oncol 2015 Jun 4;10:126. doi: 10.1186/s13014-015-0430-8.
  54. Murakami N, Kasamatsu T, Sumi M, Yoshimura R, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Itami J. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies. Radiat Oncol 2014;9:31. doi: 10.1186/1748-717X-9-31.
  55. Okamoto H, Fujita Y, Sakama K, Saitoh H, Kanai T, Itami J, Kohno T. Commissioning of 6 MV medical linac for dynamic MLC-based IMRT on Monte Carlo code GEANT4. Radiol Phys Technol 2014;7:246-53.
  56. Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, Suzuki S, Tobinai K, Uno T, Itami J. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys 2014;88:650-4.
  57. Okamoto H, Aikawa A, Wakita A, Yoshio K, Murakami N, Nakamura S, Hamada M, Abe Y, Itami J. Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system. J Radiat Res 2014;55:780-7.
  58. Masutani M, Baiseitov D, Itoh T, Hirai T, Berikkhanova K, Murakami Y, Zhumadilov Z, Imahori Y, Hoshi M, Itami J. Histological and biochemical analysis of DNA damage after BNCT in rat model. Appl Radiat Isot 2014;88:104-8.
  59. Murakami N, Kasamatsu T, Wakita A, Nakamura S, Okamoto H, Inaba K, Morota M, Ito Y, Sumi M, Itami J. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer. BMC Cancer 2014;14:447. doi: 10.1186/1471-2407-14-447.
  60. Fujibuchi T, Yonai S, Yoshida M, Sakae T, Watanabe H, Abe Y, Itami J. Measurement of activity distribution using photostimulable phosphor imaging plates in decommissioned 10 MV medical linear accelerator. Health Phys 2014;107(2 Suppl 2):S158-62.
  61. Murakami N, Mori T, Yoshimoto S, Ito Y, Kobayashi K, Ken H, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Itami J. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy. Laryngoscope 2014;124:E431-6.
  62. Murakami N, Yoshimoto S, Matsumoto F, Ueno T, Ito Y, Watanabe S, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Saito Y, Itami J. Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab. J Cancer Res Clin Oncol 2015;141:177-84.
  63. Inaba K, Okamoto H, Wakita A, Nakamura S, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Murakami N, Morota M, Ito Y, Sumi M, Uno T, Itami J. Radiotherapy for gastric lymphoma: a planning study of 3D conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy. J Radiat Res 2014;55:1141-5.
  64. Satoh T, Dokiya T, Yamanaka H, Saito S, Ishiyama H, Itami J, Shibuya H, Nakano T, Shigematsu N, Aoki M, Egawa S, Hashimoto M, Nishimura T, Yorozu A. Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan. Brachytherapy 2015;14:136-141.
  65. Murakami N, Okamoto H, Kasamatsu T, Kobayashi K, Harada K, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, Inaba K, Morota M, Sumi M, Toita T, Ito Y, Itami J. A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer. Anticancer Res 2014;34:5091-8.
  66. Tani H, Kurihara H, Hiroi K, Honda N, Yoshimoto M, Kono Y, Murakami R, Kumita S, Arai Y, Itami J. Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers. Radiother Oncol 2014;113:193-7.